Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (JPRN-jRCT2031250405) titled 'A safety and pharmacokinetic study of HP-6050 in patients with delirium, psychomotor agitation, and irritability' on Oct. 1.
Study Type: Interventional
Study Design:
single arm study, open(masking not used), uncontrolled control, single assignment, treatment purpose
Primary Sponsor: Inakura Hiroshi
Condition:
Patients with delirium, psychomotor agitation, or irritability
Intervention:
HP-6050 (Microneedle) will be applied to the skin.
Recruitment Status: Not Recruiting
Phase: 3
Date of First Enrollment: 27/10/2025
Target Sample Size: 30
To know more, visit https://jrct.mhlw.go.jp/latest-detail/...